Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWI | Common Stock | Options Exercise | $3.49M | +31.3K | +10.22% | $111.26 | 338K | Dec 16, 2021 | Direct | F1 |
transaction | AWI | Common Stock | Sale | -$2.2M | -19.9K | -5.89% | $110.65 | 318K | Dec 16, 2021 | Direct | F1, F2 |
transaction | AWI | Common Stock | Sale | -$555K | -4.97K | -1.56% | $111.66 | 313K | Dec 16, 2021 | Direct | F1, F3 |
transaction | AWI | Common Stock | Sale | -$650K | -5.77K | -1.84% | $112.75 | 307K | Dec 16, 2021 | Direct | F1, F4 |
transaction | AWI | Common Stock | Sale | -$79.6K | -700 | -0.23% | $113.65 | 307K | Dec 16, 2021 | Direct | F1, F5 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWI | Stock Options (Right to Buy) | Options Exercise | $0 | -31.3K | -50% | $0.00 | 31.3K | Dec 16, 2021 | Common Stock | 31.3K | $37.83 | Direct | F6 |
Id | Content |
---|---|
F1 | Options exercised and shares sold pursuant to a 10b5-1 Plan. Options exercised had a ten year exercise term limit and were scheduled to expire in February 2022, as reflected in this Form 4. |
F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $110.21 to $111.21. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $111.22 to $112.17. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $112.23 to $113.21. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F5 | The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $113.24 to $113.885. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F6 | The stock options were granted on February 28, 2012. Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche. All options are currently vested and exercisable. |